Cbas® heparin surface incorporates carmeda heparin manufactured from heparin sodium api, which is covalently bound to the device surface and is essentially non-eluting.The gore® viabahn® vbx balloon expandable endoprosthesis instruction for use (ifu), warning section states, do not withdraw the gore® viabahn® vbx balloon expandable endoprosthesis back into the introducer sheath once the endoprosthesis is fully introduced.Withdrawing the gore® viabahn® vbx balloon expandable endoprosthesis back into the sheath can cause dislocation and / or damage to the endoprosthesis, premature deployment, deployment failure, and / or catheter separation.If removal prior to deployment is necessary, withdraw the gore® viabahn® vbx balloon expandable endoprosthesis to a position close to but not into the introducer sheath.Both the gore® viabahn® vbx balloon expandable endoprosthesis and introducer sheath can then be removed in tandem.After removal, do not reuse the gore® viabahn® vbx balloon expandable endoprosthesis or introducer sheath.W.L.Gore & associates, inc.(gore) is submitting this report to comply with 21 c.F.R.Part 803, the medical device reporting regulation.This report is based upon information obtained by gore, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.This report does not constitute an admission or a conclusion by fda, gore, or its associates that the device, gore or its associates caused or contributed to the event described in the report.In particular, this report does not constitute a legal admission by anyone that the product described in this report has any defects or has malfunctioned, as defined from a legal standpoint.These words are included in the report and are fixed items for selection created by the fda, to categorize the type of event solely for the purpose of reporting pursuant to part 803.This statement should be included with any information or report disclosed to the public under the freedom of information act.
|
On (b)(6) 2023, the patient underwent treatment in the superior mesenteric artery (sma) for peripheral arterial disease using a 7 mm x 39 mm gore® viabahn® vbx balloon expandable endoprosthesis (vbx device).It was reported the physician accessed the treatment area using a 7f destino steerable guiding sheath and an unknown brand 0.035" guidewire.Reportedly, the delivery system catheter met some resistance during advancement.The vbx device would not advance into the sma.The decision was made to withdraw the device from the patient.An attempt was made to pull the stent back into the introducer sheath.The balloon was pulled into the introducer sheath, but the undeployed stent dislodged and was left in the aorta.The stent was successfully removed from the aorta using a snare catheter.The physician decided to conclude the procedure without further intervention.No impact to the patient was reported.
|